Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries. Hetero Benin Burkina Faso Burundi Cameroon Chad Comoros Cote d'Ivoire Djibouti Ethiopia Gabon Gambia Ghana Guinea Equatorial Guinea Kenya Liberia Madagascar Mali Niger Namibia Nigeria Central African Republic Congo, The Democratic Republic of the Congo, The Republic of the Senegal Sierra Leone South Africa Sudan Tanzania Tonga Uganda Zambia Zimbabwe Algeria Angola Botswana Cape Verde Egypt Eritrea Guinea-Bissau Lesotho Libya Malawi Mauritania Mauritius Morocco Mozambique Rwanda Sao Tome and Principe Seychelles South Sudan Swaziland Togo Tunisia Germany France United Kingdom Spain Mexico Italy India Switzerland Thailand Netherlands